@article{Cernesi_Buquicchio_Ventura_Boni_2018, title={Intramuscular epinephrine as first-line treatment of anaphylaxis: still concerns about its safety in the elderly?}, volume={66}, url={https://www.jgerontology-geriatrics.com/article/view/102}, abstractNote={<p>Anaphylaxis is a severe condition that can affect patients of all ages. Elderly patients must be considered<br>particularly vulnerable to severe anaphylaxis due to many risk factors such as concomitant diseases and medications.<br>Intramuscular administration of epinephrine is recommended as fist-line therapy for anaphylaxis and<br>its use should be promoted in every setting. Intramuscular epinephrine is recognized as generally safe and<br>there are no absolute contraindications to the prescription of self-injectable adrenaline in older patients at risk<br>of anaphylaxis.</p&gt;}, number={1}, journal={JOURNAL OF GERONTOLOGY AND GERIATRICS}, author={Cernesi, S. and Buquicchio, R. and Ventura, M.T. and Boni, E.}, year={2018}, month={Mar.}, pages={43-45} }